Hydrochloric Acid

Hydrochloric Acid

SCHEMBL248062

C=C(C)C(=O)OCC(NC)(NC)NC.Cl

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
ALDH1A1 P00352 2/20 0.43
THRB P10828 1/20 0.41
POLB P06746 1/20 0.31
APEX1 P27695 1/20 0.31
HTT P42858 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676411 0.98 TSHR (0.45) TSHRALDH1A1THRBPOLBAPEX1
Sulfuric Acid SCHEMBL8720200 0.91 TSHR (0.40) TSHRALDH1A1THRB
SCHEMBL547837 0.86 ALDH1A1 (0.39) TSHRALDH1A1THRB
Hydrochloric Acid SCHEMBL1237638 0.81 THRB (0.43) TSHRALDH1A1THRB
Hydrochloric Acid SCHEMBL5538296 0.81 THRB (0.47) TSHRALDH1A1THRBPOLBAPEX1
SCHEMBL14994268 0.80 TSHR (0.44) TSHRALDH1A1THRBPOLBAPEX1
SCHEMBL10495130 0.78 THRB (0.48) TSHRALDH1A1THRBPOLBAPEX1
SCHEMBL2939730 0.78 THRB (0.44) TSHRALDH1A1THRBPOLBAPEX1
SCHEMBL4948171 0.77 THRB (0.43) TSHRALDH1A1THRB
SCHEMBL57880 0.76 TSHR (0.52) TSHRALDH1A1THRBPOLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999901-B2 Multifunctional wax dispersant for subterranean chemical applications EVONIK OPERATIONS GMBH (DE) 2024-06-04 US claimed
CN-117717531-A Pivelum bromide tablet and preparation method thereof 广州仁恒医药科技股份有限公司 2024-03-19 CN claimed
US-20240000701-A1 SELF-REGULATING OSMOTIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS AMNEAL COMPLEX PRODUCTS RESEARCH LLC (US) 2024-01-04 US claimed
US-20230416596-A1 MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS EVONIK OPERATIONS GMBH (DE) 2023-12-28 US claimed
CN-117257748-A Exemestane film coated tablet and preparation method thereof 泊诺(天津)创新医药研究有限公司 2023-12-22 CN claimed
CN-117279638-A Extended release compositions comprising pistigmine 安尼尔复合产品资源有限公司 2023-12-22 CN claimed
CN-115397416-B Pharmaceutical composition containing molecular level of lenvatinib, preparation method and application thereof 北京睿创康泰医药研究院有限公司 2023-12-05 CN claimed
WO-2023226160-A1 SUPER-SWELLING MICRONEEDLE PATCH, AND PREPARATION METHOD THEREFOR AND USE THEREOF 迈德科莱(杭州)生物技术有限公司 2023-11-30 WO claimed
CN-114272385-B Targeted release film coating premix and application thereof 北京英茂药业有限公司 2023-11-14 CN claimed
US-20230348777-A1 MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS EVONIK OPERATIONS GMBH (DE) 2023-11-02 US claimed
US-20110117194-A1 PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER HANALL BIOPHARMA CO., LTD. (KR) 2011-05-19 US claimed
EP-2281557-A2 PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER HanAll Biopharma Co., Ltd. (KR) 2011-02-09 EP claimed
EP-1909741-B1 denture support composition RECKITT BENCKISER UK LTD (GB) 2010-11-10 EP claimed
US-7381417-B2 Fragrance delivery system for surface cleaners and conditioners FIRMENICH SA (CH) 2008-06-03 US claimed
EP-1909741-A2 COMPOSITION Reckitt Benckiser (UK) LIMITED (GB) 2008-04-16 EP claimed
WO-2007012859-A2 DENTURE SUPPORT COMPOSITION RECKITT BENCKISER (UK) LIMITED (GB) 2007-02-01 WO claimed
WO-2005105036-A1 CONTROLLED RELEASE MUCOADHESIVE MATRIX FORMULATION CONTAINING TOLTERODINE AND A PROCESS FOR ITS PREPARATION NATCO PHARMA LIMITED (IN) 2005-11-10 WO claimed
WO-2005079748-A2 PHARMACEUTICAL PREPARATION FOR SUSTAINED RELEASE OF A PHARMACEUTICALLY ACTIVE INGREDIENT LACER, S.A. (ES) 2005-09-01 WO claimed
US-5783533-A COPOLYMER CONTAINING ACRYLIC ACID TYPE GROUPS, ACRYLIC, VINYL, OR ALLYL MONOMERS WITH PENDANT AMMONIUM OR SULFONIUM GROUPS, POSSIBLY WITH POLYOXYALKYLENE ETHER SECTION, RHEOLOGY MODIFIERS COATEX S.A. (FR) 1998-07-21 US claimed
EP-0580529-B1 Process for making paper or cardboard having improved retention S N F (FR) 1996-04-17 EP claimed